Genome Medicine (Feb 2021)

CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes

  • Dave J. Baker,
  • Alp Aydin,
  • Thanh Le-Viet,
  • Gemma L. Kay,
  • Steven Rudder,
  • Leonardo de Oliveira Martins,
  • Ana P. Tedim,
  • Anastasia Kolyva,
  • Maria Diaz,
  • Nabil-Fareed Alikhan,
  • Lizzie Meadows,
  • Andrew Bell,
  • Ana Victoria Gutierrez,
  • Alexander J. Trotter,
  • Nicholas M. Thomson,
  • Rachel Gilroy,
  • Luke Griffith,
  • Evelien M. Adriaenssens,
  • Rachael Stanley,
  • Ian G. Charles,
  • Ngozi Elumogo,
  • John Wain,
  • Reenesh Prakash,
  • Emma Meader,
  • Alison E. Mather,
  • Mark A. Webber,
  • Samir Dervisevic,
  • Andrew J. Page,
  • Justin O’Grady

DOI
https://doi.org/10.1186/s13073-021-00839-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Abstract We present CoronaHiT, a platform and throughput flexible method for sequencing SARS-CoV-2 genomes (≤ 96 on MinION or > 96 on Illumina NextSeq) depending on changing requirements experienced during the pandemic. CoronaHiT uses transposase-based library preparation of ARTIC PCR products. Method performance was demonstrated by sequencing 2 plates containing 95 and 59 SARS-CoV-2 genomes on nanopore and Illumina platforms and comparing to the ARTIC LoCost nanopore method. Of the 154 samples sequenced using all 3 methods, ≥ 90% genome coverage was obtained for 64.3% using ARTIC LoCost, 71.4% using CoronaHiT-ONT and 76.6% using CoronaHiT-Illumina, with almost identical clustering on a maximum likelihood tree. This protocol will aid the rapid expansion of SARS-CoV-2 genome sequencing globally.

Keywords